Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ErbB2-Positive Stage I-III Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Very early researchStudy completedNCT00640861
What this trial is testing

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 45
Not applicableStudy completedNCT03715959
What this trial is testing

Nipple Aspirate Fluid in Detecting Breast Cancer

Who this might be right for
Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+25 more
Ohio State University Comprehensive Cancer Center 2
Not applicableStudy completedNCT01562288
What this trial is testing

Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 1,576
Testing effectiveness (Phase 2)Study completedNCT01355393
What this trial is testing

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+5 more
University of Washington 50
Early research (Phase 1)Study completedNCT00436254
What this trial is testing

Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer

Who this might be right for
HER2-positive Breast CancerStage III Ovarian Epithelial CancerStage III Ovarian Germ Cell Tumor+6 more
University of Washington 66
Testing effectiveness (Phase 2)Study completedNCT02789657
What this trial is testing

Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.

Who this might be right for
Breast Cancer
Brown University 32
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Testing effectiveness (Phase 2)Study completedNCT01750073
What this trial is testing

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+13 more
University of Nebraska 92
Not applicableLooking for participantsNCT06723990
What this trial is testing

Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
European Institute of Oncology 60
Testing effectiveness (Phase 2)Looking for participantsNCT07631052
What this trial is testing

Capecitabine in ER+/HER2-negative Breast Cancer

Who this might be right for
ER-positive, HER2-negative Breast CancerBreast Cancer Stage IBreast Cancer Stage II+1 more
University Health Network, Toronto 15
Not applicableLooking for participantsNCT06534125
What this trial is testing

Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
Emory University 150
Large-scale testing (Phase 3)Temporarily pausedNCT06671912
What this trial is testing

Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8+4 more
Alliance for Clinical Trials in Oncology 1,556
Testing effectiveness (Phase 2)WithdrawnNCT04038489
What this trial is testing

COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast Cancer
University of Virginia
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Large-scale testing (Phase 3)Looking for participantsNCT01785420
What this trial is testing

Pre Operative Trastuzumab in Operable Breast Cancer

Who this might be right for
Carcinoma Breast Stage IHER2 Positive Breast Cancer
Dr Rajendra A. Badwe 1,100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05319873
What this trial is testing

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+17 more
Jonsson Comprehensive Cancer Center 18
Large-scale testing (Phase 3)Active Not RecruitingNCT02488967
What this trial is testing

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaEstrogen Receptor NegativeHER2/Neu Negative+7 more
NRG Oncology 782